MedPage Today on MSN
Could This Be the First Disease-Modifying Drug in Bronchiectasis?
CHICAGO -- Brensocatib (Brinsupri) appeared to have a disease-modifying effect on structural lung changes in non-cystic ...
The use of CT scans is moving beyond a simple diagnostic tool for non–cystic fibrosis bronchiectasis to become a practical ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Bronchiectasis ...
Insmed's DPP1 inhibitor Brinsupri (brensocatib) has been recommended by the CHMP for the treatment of patients aged 12 and ...
If Approved, BRINSUPRI Would Be the First and Only Treatment in the European Union for Non-Cystic Fibrosis Bronchiectasis ...
Brensocatib effectively reduces NSP activity in bronchiectasis patients, with greater reductions observed in the 25-mg dose group compared to the 10-mg group.
No difference in the risk for eczema or bronchiolitis were noted at 1 year of age with as needed use of acetaminophen or ibuprofen.
Researchers identified two types of olfactory receptors in human muscle cells of bronchi. If those receptors are activated by binding an odorant, bronchi dilate and contract -- a potential approach ...
Newly shared preliminary data suggests that the Omicron variant of SARS-CoV-2 may target and infect tissues within the respiratory tract at different rates than do the Delta variant and other ...
Asthma is a respiratory condition marked by spasms in the bronchi of the lungs, causing difficulty in breathing. Today, flare-ups of asthma are typically self-treated through the use of an inhaler ...
The trachea, also called the windpipe, is part of the passageway that supplies air to the lungs. Any prolonged blockage, even for a few minutes, can cause death. The trachea is about 4.5 inches long ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results